Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Two Birds with One Stone? Possible Dual-Targeting H1N1 Inhibitors from Traditional Chinese Medicine

Two Birds with One Stone? Possible Dual-Targeting H1N1 Inhibitors from Traditional Chinese Medicine

Thumbnail Image
Download
Name

Chang-2011-Two birds with one s.pdf

Size

2.52 MB

Format

Adobe PDF

Checksum (MD5)

997940f2941681d085d310e0be9f6b58

Author(s)
Chen, Yu-Chian
•
Chang, Su-Sen
•
Huang, Hung-Jin
Date Issued
December 2011
Journal
PLoS Computational Biology
Publisher
Public Library of Science
Citation
Chang, Su-Sen, Hung-Jin Huang, and Calvin Yu-Chian Chen. “Two Birds with One Stone? Possible Dual-Targeting H1N1 Inhibitors from Traditional Chinese Medicine.” Ed. Kuo-Chen Chou. PLoS Computational Biology 7.12 (2011): e1002315. Web. 8 Feb. 2012.
Version
Final published version
Abstract
The H1N1 influenza pandemic of 2009 has claimed over 18,000 lives. During this pandemic, development of drug resistance further complicated efforts to control and treat the widespread illness. This research utilizes traditional Chinese medicine Database@Taiwan (TCM Database@Taiwan) to screen for compounds that simultaneously target H1 and N1 to overcome current difficulties with virus mutations. The top three candidates were de novo derivatives of xylopine and rosmaricine. Bioactivity of the de novo derivatives against N1 were validated by multiple machine learning prediction models. Ability of the de novo compounds to maintain CoMFA/CoMSIA contour and form key interactions implied bioactivity within H1 as well. Addition of a pyridinium fragment was critical to form stable interactions in H1 and N1 as supported by molecular dynamics (MD) simulation. Results from MD, hydrophobic interactions, and torsion angles are consistent and support the findings of docking. Multiple anchors and lack of binding to residues prone to mutation suggest that the TCM de novo derivatives may be resistant to drug resistance and are advantageous over conventional H1N1 treatments such as oseltamivir. These results suggest that the TCM de novo derivatives may be suitable candidates of dual-targeting drugs for influenza.
MIT Department
Massachusetts Institute of Technology. Computational and Systems Biology Program
Terms of Use
Creative Commons Attribution
http://creativecommons.org/licenses/by/2.5/
Persistent DSpace Link
http://hdl.handle.net/1721.1/69046
DOI of Published Version
https://doi.org/10.1371/journal.pcbi.1002315
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.